Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Seeking Alpha • Dec 4, 2025

30% of the S&P 500 Is Mag 7 Tech Stocks, but This ETF Refuses to Own a Single One

The Magnificent 7 AI tech stocks have served as the rocket fuel propelling the S&P 500 on its bull run over the past few years.

24/7 Wall Street • Dec 2, 2025

Agilent (A) International Revenue Performance Explored

Examine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Zacks Investment Research • Dec 1, 2025

Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc (NYSE: A) today announced the release of a new 21 CFR Part 11 compliance software for the Agilent xCELLigence Real-Time Cell Analysis (RTCA) eSight system. The software includes a compliance license and enhanced security features, allowing this multiplex live-cell analysis system to be deployed not only in drug discovery and development labs but now also in GMP-regulated manufacturing and quality control settings. Extending the plat.

Business Wire • Dec 1, 2025

5 Stocks Worth Watching on Recent Dividend Hikes

A group of dividend raisers OBT, UBSI, DDS, PATK and A stand out as investors seek stability amid volatile markets, rate-cut hopes and mixed economic signals.

Zacks Investment Research • Nov 28, 2025

Agilent Technologies: Steady As She Goes

Agilent Technologies delivered strong Q4 2025 results, with revenue and EPS beating expectations and robust growth in Life Sciences and Diagnostics segment. Management forecasts FY26 revenue growth of 6% and normalized EPS between $5.86 and $6.00, signaling continued solid performance. Agilent now trades at a 6% premium to fair value after a 23% rally, outpacing the S&P 500 handily since my August coverage.

Seeking Alpha • Nov 26, 2025

These Analysts Boost Their Forecasts On Agilent After Upbeat Q4 Results

Agilent Technologies Inc (NYSE: A) reported upbeat earnings for the fourth quarter on Monday.

Benzinga • Nov 25, 2025

Agilent Q4 Earnings Match Estimates, Revenues Up Y/Y, Shares Fall

A report higher Q4 revenues and lifts its 2026 outlook, yet the stock slips as margins narrow across key business segments.

Zacks Investment Research • Nov 25, 2025

Agilent Technologies, Inc. (A) Q4 2025 Earnings Call Transcript

Agilent Technologies, Inc. ( A ) Q4 2025 Earnings Call November 24, 2025 4:30 PM EST Company Participants Tejas Savant Padraig McDonnell - CEO, President & Director Adam Elinoff - Senior VP, CFO & Principal Financial Officer Rodney Gonsalves - Principal Accounting Officer, VP & Corporate Controller Simon May - SVP & President of LDG Angelica Riemann - Senior VP & President of Agilent CrossLab Group Mike Zhang - Senior VP & President of Applied Markets Group Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Patrick Donnelly - Citigroup Inc., Research Division Daniel Leonard - UBS Investment Bank, Research Division Douglas Schenkel - Wolfe Research, LLC Brandon Couillard - Wells Fargo Securities, LLC, Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Jack Meehan - Nephron Research LLC Daniel Brennan - TD Cowen, Research Division Michael Ryskin - BofA Securities, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Casey Woodring - JPMorgan Chase & Co, Research Division Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division Luke Sergott - Barclays Bank PLC, Research Division Presentation Operator Good afternoon.

Seeking Alpha • Nov 25, 2025

Agilent Technologies, Inc. (A) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Agilent Technologies, Inc. ( A ) Bank of America Global Healthcare Conference 2025 September 25, 2025 4:50 AM EDT Company Participants Padraig McDonnell - CEO, President & Director Conference Call Participants Michael Ryskin - BofA Securities, Research Division Presentation Michael Ryskin BofA Securities, Research Division I'm Mike Ryskin. I'm on the Bank of America Life Science Tools and Diagnostics team based in New York.

Seeking Alpha • Nov 25, 2025